[Pro-survival signaling pathways activated by BCR-ABL oncogene in chronic myelogenous leukemia cells: the role of the perk-EIF2α signal path and acetylation of p53].

Subjects

Subjects :

Benzamides pharmacology
Drug Resistance, Neoplasm genetics
History, 21st Century
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Phosphorylation
Piperazines pharmacology
Pyrimidines pharmacology
Translocation, Genetic genetics
Tumor Cells, Cultured
Eukaryotic Initiation Factor-2 metabolism
Fusion Proteins, bcr-abl metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism
Signal Transduction physiology
eIF-2 Kinase metabolism

Details

Language :

Polish

ISSN :

0032-5422

Volume :

60

Issue :

4

Database :

MEDLINE

Journal :

Postepy biochemii

Publication Type :

Academic Journal

Accession number :

25807820